Real‐World Treatment Patterns in AERD: An Analysis of ATAD, Biologics, and Combination Therapy
Contemporary aspirin exacerbated respiratory disorder (AERD) therapy commonly includes aspirin desensitization (55%) and biologics (48%). Aspirin desensitization therapy has higher discontinuation rates than biologics. Patients receiving biologics are younger, and ∼25% of the patients switch to other agents.
Authors
- Devyani Lal (ORCID: https://orcid.org/0000-0002-7593-2385)
- Amar Miglani (ORCID: https://orcid.org/0000-0002-0708-4345)
- Pedro Lança Gomes (ORCID: https://orcid.org/0000-0002-6422-5271)
- Tyson Pace
- Michael J. Marino (ORCID: https://orcid.org/0000-0002-8672-0310)
- Nitish Kumar (ORCID: https://orcid.org/0000-0001-9923-9254)
Institutions
- Universidade de Brasília (BR)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- International Forum of Allergy & Rhinology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1002/alr.70072
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00